Recurrent Mantle Cell Lymphoma Clinical Trials in Houston

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
M
Terminated
  • Central Nervous System Lymphoma
  • +6 more
  • Akt/ERK Inhibitor ONC201
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-03-30
Mar 30, 2022
M
Withdrawn
  • Recurrent Mantle Cell Lymphoma
  • Refractory Mantle Cell Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
2022-02-23
Feb 23, 2022
M
Active, not recruiting
  • CCND1 Positive
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-01-11
Jan 11, 2022
V
Active, not recruiting
  • Blastoid Variant Mantle Cell Lymphoma
  • +8 more
  • Birmingham, Alabama
  • +4 more
2021-11-09
Nov 9, 2021
M
Recruiting
  • Recurrent Mantle Cell Lymphoma
  • Refractory Mantle Cell Lymphoma
  • Low Dose Radiation Therapy
  • Houston, Texas
    M D Anderson Cancer Center
2021-10-01
Oct 1, 2021
M
Terminated
  • B Acute Lymphoblastic Leukemia With t(v;11q23.3); KMT2A Rearranged
  • +16 more
  • Autologous CD19-CD8-CD28-CD3zeta-CAR-mbIL15-HER1t T Cells
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-05-28
May 28, 2021
M
Recruiting
  • Recurrent Mantle Cell Lymphoma
  • Refractory Mantle Cell Lymphoma
  • Biospecimen Collection
  • Follow-Up
  • Houston, Texas
    M D Anderson Cancer Center
2021-04-30
Apr 30, 2021
M
Recruiting
  • Blastoid Variant Mantle Cell Lymphoma
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-02-21
Feb 21, 2021
N
Completed
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +35 more
  • Akt inhibitor MK2206
  • laboratory biomarker analysis
  • Houston, Texas
    M D Anderson Cancer Center
2020-10-14
Oct 14, 2020
M
Unknown status
  • Recurrent Mantle Cell Lymphoma
  • Refractory Mantle Cell Lymphoma
  • Best Practice
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
2020-03-23
Mar 23, 2020
M
Recruiting
  • Recurrent Mantle Cell Lymphoma
  • Refractory Mantle Cell Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
2020-01-31
Jan 31, 2020
N
Completed
  • MYC Positive
  • +16 more
  • Houston, Texas
    M D Anderson Cancer Center
2019-01-25
Jan 25, 2019
M
Completed
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +45 more
  • anti-endosialin/TEM1 monoclonal antibody MORAb-004
  • +2 more
  • Birmingham, Alabama
  • +19 more
2016-01-07
Jan 7, 2016
N
Completed
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
  • +16 more
  • recombinant interleukin-12
  • laboratory biomarker analysis
  • Houston, Texas
    M D Anderson Cancer Center
2015-04-14
Apr 14, 2015
N
Completed
  • Anaplastic Large Cell Lymphoma
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
2014-05-21
May 21, 2014
N
Completed
  • Cutaneous B-cell Non-Hodgkin Lymphoma
  • +20 more
  • oblimersen sodium
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
2014-05-13
May 13, 2014
N
Completed
  • Anaplastic Large Cell Lymphoma
  • +5 more
  • Chicago, Illinois
  • +1 more
2014-05-07
May 7, 2014
N
Terminated
  • Recurrent Adult Diffuse Large Cell Lymphoma
  • Recurrent Mantle Cell Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
2014-05-02
May 2, 2014
N
Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +50 more
  • Akt inhibitor MK2206
  • +2 more
  • Birmingham, Alabama
  • +24 more
2014-04-28
Apr 28, 2014
N
Completed
  • Adult Grade III Lymphomatoid Granulomatosis
  • +61 more
  • bevacizumab
  • cediranib maleate
  • Houston, Texas
    M D Anderson Cancer Center
2014-02-14
Feb 14, 2014
B
Withdrawn
  • Contiguous Stage II Mantle Cell Lymphoma
  • +4 more
  • antineoplaston A10
  • +7 more
  • Houston, Texas
    Burzynski Clinic
2013-07-09
Jul 9, 2013
N
Completed
  • Angioimmunoblastic T-cell Lymphoma
  • +16 more
  • Houston, Texas
    M D Anderson Cancer Center
2013-01-22
Jan 22, 2013